Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers
Randomized Standard-of-Care-Controlled Trial of a Silica Gel Fiber (SGF) Wound Dressing in the Treatment of Chronic Venous Leg Ulcers
Sponsor: Bayer
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Bayer
Other Venous Ulcer trials with similar outcome
This PHASE2 trial investigates Venous Ulcer and is currently terminated or withdrawn. Bayer leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Apr 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Bochum, Germany , Bonn, Germany , Cologne, Germany , Dresden, Germany , Essen, Germany , Frankfurt, Germany , Freiburg im Breisgau, Germany , Greifswald, Germany , Göttingen, Germany and 4 more locations